Acceleron Pharma Inc EV/Sales
Quel est le EV/Sales de Acceleron Pharma Inc?
Le EV/Sales de Acceleron Pharma Inc est 91.88
Quelle est la définition de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales des entreprises dans Health Care secteur sur NASDAQ par rapport à Acceleron Pharma Inc
Que fait Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Entreprises avec ev/sales similaire à Acceleron Pharma Inc
- Eaton Vance Tax-Managed Global Diversified Equity Income Fund a EV/Sales de 90.79
- genedrive plc a EV/Sales de 90.81
- Royce Micro-Cap Trust Inc a EV/Sales de 91.14
- Fairfax India a EV/Sales de 91.22
- Honda Motor a EV/Sales de 91.24
- Novonix a EV/Sales de 91.58
- Acceleron Pharma Inc a EV/Sales de 91.88
- China Huarong a EV/Sales de 91.97
- Zeotech a EV/Sales de 92.09
- Castillo Copper a EV/Sales de 92.20
- Carnival International a EV/Sales de 92.27
- Imagion Biosystems a EV/Sales de 92.51
- Syntonic a EV/Sales de 92.53